Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-1.53%
↑ 63% above average
Average (5y)
-4.12%
Historical baseline
Range
High:-0.37%
Low:-11.10%
CAGR
+33.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -1.53% | +86.2% |
| 2023 | -11.10% | -22.8% |
| 2022 | -9.04% | -298.5% |
| 2021 | -2.27% | -443.3% |
| 2020 | -0.42% | -14.1% |
| 2019 | -0.37% | - |